mevalonic acid has been researched along with Chromosomal Translocation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, DW; Branchard, E; Haibe-Kains, B; Keats, JJ; Li, Z; Licht, JD; Longo, J; Penn, LZ; Pugh, TJ; Smirnov, P; Trudel, S; van Leeuwen, JE | 1 |
Haberbosch, W; Hölschermann, H; Muth, H; Parviz, B; Schuster, D; Tillmanns, H | 1 |
2 other study(ies) available for mevalonic acid and Chromosomal Translocation
Article | Year |
---|---|
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bortezomib; Cell Proliferation; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Female; Fluvastatin; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Polyisoprenyl Phosphates; Translocation, Genetic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.
Topics: Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I-kappa B Kinase; I-kappa B Proteins; Mevalonic Acid; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Pyridines; Signal Transduction; Thromboplastin; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Translocation, Genetic; Tumor Necrosis Factor-alpha | 2006 |